Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients-Reference-Cited by-同舟云学术

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients

Published:2021-10 Issue:10 Volume:17 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Molecular Systems Biology

Author:

Zeybel Mujdat¹²³,Altay Ozlem⁴,Arif Muhammad⁴^ORCID,Li Xiangyu⁴,Yang Hong⁴,Fredolini Claudia⁴,Akyildiz Murat³,Saglam Burcin³,Gonenli Mehmet Gokhan³^ORCID,Ural Dilek⁵^ORCID,Kim Woonghee⁴,Schwenk Jochen M⁴^ORCID,Zhang Cheng⁴⁶^ORCID,Shoaie Saeed⁴⁷,Nielsen Jens⁸^ORCID,Uhlén Mathias⁴,Borén Jan⁹^ORCID,Mardinoglu Adil⁴⁷^ORCID

Affiliation:

1. NIHR Nottingham Biomedical Research Centre Nottingham University Hospitals NHS Trust & University of Nottingham Nottingham UK

2. Nottingham Digestive Diseases Centre, School of Medicine University of Nottingham Nottingham UK

3. Department of Gastroenterology and Hepatology, School of Medicine Koç University Istanbul Turkey

4. Science for Life Laboratory KTH ‐ Royal Institute of Technology Stockholm Sweden

5. Department of Cardiology, School of Medicine Koç University Istanbul Turkey

6. School of Pharmaceutical Sciences Zhengzhou University Zhengzhou China

7. Centre for Host‐Microbiome Interactions, Faculty of Dentistry Oral & Craniofacial Sciences, King’s College London London UK

8. Department of Biology and Biological Engineering Chalmers University of Technology Gothenburg Sweden

9. Department of Molecular and Clinical Medicine University of Gothenburg and Sahlgrenska University Hospital Gothenburg Sweden

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.202110459

Reference61 articles.

1. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study

2. Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study

3. Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

4. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases

5. From NASH to HCC: current concepts and future challenges

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cocktail of histidine, carnosine, cysteine and serine reduces adiposity and improves metabolic health and adipose tissue immunometabolic function in ovariectomized rats;Biomedicine & Pharmacotherapy;2024-10

2. Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases;Biomedicines;2024-04-22

3. Tryptophan metabolism and liver fibrosis;World Chinese Journal of Digestology;2024-03-28

4. Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese;Cell Reports Medicine;2023-11

5. Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD;Journal of Inflammation Research;2023-11